wegovy (Credit: Canva)
People receiving weight-loss drug Wegovy sustained weight loss for up to four years, shedding an average of 10% of their body weight in that time, as per a new study. Wegrovy is a brand that markets semaglutide injections, that have gained widespread attention for their weight-loss effects. The study also found that Semaglutide injections boost an individual's heart health, even when weight loss doesn't take place.
The study, called SELECT, was published in journal Nature Medicine. "At four years, we see ongoing benefits of semaglutide," said Cheng-Han Chen, MD, interventional cardiologist from Cardiologist, who was not involved in the research. Besides the weight loss, it also lead to a loss in cardiovascular outcomes.
The research was conducted on 17000 adults, who had obesity but did not have diabetes. Overall, people who received once-weekly injections of semaglutide lost on average 10.2% of their body weight over the course of four years. All of the study participants continued to lose weight for about 65 weeks, a year and three months, and then their weight remained at a stable level.
Of the people on the highest dose of Wegovy, 68% lost at least 5% of their body weight. This compared to 21% of people on the placebo. Additionally, of the total people on Wegovy about 23% lost at least 15% of their body weight. For those in the placebo group, only 1.7% lost that much body weight.
Researchers found that even individuals who did not experience significant weight reduction while on the drug saw a reduced risk of major heart events. Recent analysis of the SELECT trial data revealed that semaglutide significantly lowers the risk of heart attack, stroke, and cardiovascular-related deaths in adults with obesity or those who are overweight. Notably, the results of this study lead the US FDA to approve Novo Nordisk's Wegovy for reducing heart-related risks in this group.
Semaglutide, marketed under the brand name Wegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. It is also an anti-obesity drug used for long-term weight management. While it can be taken as a subcutaneous injection or orally, it has significant side effects. It primarily impacts your gastrointestinal tract and its side effects include constipation, nausea, abdominal pain, diarrhoea, and fatigue amongst others.
Credits: Canva
New research suggests that menopause may be linked to a loss of grey matter in the brain, which could help explain why women face a higher risk of dementia compared to men. Scientists from the University of Cambridge analysed data from 124,780 women to explore how menopause affects the brain and whether hormone replacement therapy (HRT) might help protect against cognitive decline.
The researchers found that menopause was associated with reduced levels of grey matter, an essential part of the brain involved in thinking, memory, emotional processing and movement. The findings also noted that this stage of life is often accompanied by anxiety, depression and sleep problems. Previous research has already shown that menopause can affect cognitive abilities such as attention, language, learning and memory.
Published in the journal Psychological Medicine, the research divided participants into three groups: women who had not yet reached menopause, post-menopausal women who had never used HRT, and post-menopausal women who were taking HRT. Participants answered questions about sleep patterns, anxiety and depression, and some completed cognitive tests measuring memory and reaction time.
Around 11,000 women also underwent magnetic resonance imaging (MRI) scans, allowing scientists to closely examine brain structure. On average, menopause began at age 49 among the participants, and women who started HRT typically began treatment at around the same age.
The findings showed that post-menopausal women were more likely to struggle with insomnia, get less sleep overall and feel more fatigued. Interestingly, women using HRT reported the highest levels of tiredness across all three groups, even though they slept for a similar amount of time as those not taking HRT.
All post-menopausal women, regardless of whether they were using hormone therapy, reported greater fatigue compared to women who had not yet experienced menopause. Researchers also observed that this stage of life had an impact on cognitive function.
Dr Katharina Zuhlsdorff, from the psychology department at the University of Cambridge, explained: “As we age, our reaction times naturally slow down. This happens to both women and men and is part of normal ageing. You might still reach the right answer to a quiz question, but younger people tend to respond faster. Our findings suggest menopause speeds up this slowing process, while HRT seems to slow it down slightly.”
The study identified significant reductions in grey matter volume among post-menopausal women. These changes were seen in the hippocampus, which plays a key role in learning and memory, the entorhinal cortex, which supports memory formation and spatial awareness, and the anterior cingulate cortex, which helps regulate attention and emotions.
Professor Barbara Sahakian, the senior author of the study from the department of psychiatry, said: “The brain areas where we observed these changes are the same regions commonly affected by Alzheimer’s disease. Menopause may make women more vulnerable later in life. While it does not explain everything, it could help clarify why dementia affects nearly twice as many women as men.”
Michelle Dyson, chief executive of the Alzheimer’s Society, noted that women account for roughly two-thirds of people living with Alzheimer’s disease in the UK. “Although we do not yet fully understand why women are more affected than men, hormones are thought to play a role,” she said.
“This large-scale study strengthens evidence that menopause has an impact on the brain, including physical changes such as reduced brain volume. However, without long-term follow-up to see whether participants later develop dementia, we cannot be certain that these menopause-related brain changes directly increase dementia risk.
“There are steps people can take today to lower their dementia risk, including regular exercise, avoiding smoking and cutting back on alcohol. Anyone concerned about themselves or a loved one can use the Alzheimer’s Society dementia symptoms checklist as a starting point before speaking to a GP.”
The research also found that women taking HRT were more likely to report mental health challenges. However, the analysis suggested these women already had poorer psychological wellbeing before starting hormone treatment.
Dr Christelle Langley, from the psychiatry department, said: “Menopause is something most women will experience, and it can be a major life change whether or not HRT is used. During this time, healthy habits such as staying active, exercising regularly and eating a balanced diet become especially important to help reduce some of its effects.”
Dr Louise Newson, a GP and women’s hormone specialist, added: “Many women notice changes in memory and concentration around menopause. This study suggests these symptoms may have a biological explanation rather than being brushed off as stress or ageing, highlighting menopause as a key window for protecting brain health and providing personalised care.”
Credits: AI Generated
More than 10 million adults, young people, and children in the UK are currently living with arthritis, according to a 2025 report by Arthritis UK. The NHS states that osteoarthritis is the most common form of the condition nationwide.
As per Cleveland Clinic, osteoarthritis develops gradually as joints become stiff and painful due to wear and tear. Symptoms can vary depending on the joint affected and the extent of damage, but pain, swelling, and reduced movement are common. While medication is often prescribed to manage symptoms, the NHS cautions that some commonly used treatments can carry health risks if taken long-term or without proper guidance.
One of the most frequently used pain relief options is non-steroidal anti-inflammatory drugs, commonly known as NSAIDs.
NSAIDs, or non-steroidal anti-inflammatory drugs, are commonly prescribed by GPs to help relieve pain, swelling, and inflammation. They are available in several forms, including tablets, capsules, suppositories, creams, gels, and injections. Some NSAIDs can be purchased over the counter, while stronger versions require a prescription.
These medicines are often relied upon for day-to-day pain relief by people with osteoarthritis, particularly during flare-ups.
The NHS advises that NSAIDs may not be suitable for everyone. Extra caution is recommended for people with asthma, a history of stomach ulcers, angina, or those who have previously experienced a heart attack or stroke. The NHS also advises that individuals taking low-dose aspirin should always consult their GP before using NSAIDs.
Long-term or incorrect use can increase the risk of stomach bleeding, cardiovascular problems, and kidney issues, making it important to review pain management plans regularly.
Consultant Rheumatologist Dr Rod Hughes explains that natural compounds are increasingly being explored as supportive options for joint health.
“Natural compounds derived from plants have long been used in both traditional and modern medicine to support joint health. One such compound is GOPO, which is derived from rose hips (Rosa canina). Research indicates that GOPO can help relieve joint pain due to its anti-inflammatory properties,” he says.
“Rather than simply masking symptoms, GOPO works by helping to regulate the body’s inflammatory response, which is a key driver of joint stiffness, swelling, and discomfort. It offers a promising alternative to traditional painkillers, with fewer risks of side effects, making it a more sustainable option for managing joint discomfort.”
According to Dr Hughes, lifestyle measures form the foundation of osteoarthritis management.
“Lifestyle choices play a central role in relieving osteoarthritis pain and helping people stay active,” he explains. “Research shows that regular, gentle exercise supported by physiotherapy, such as walking, swimming, and yoga, can be highly effective.”
“These activities help keep joints mobile and strengthen the muscles and ligaments that support them, which reduces stiffness and eases pressure on painful joints. It is also important to balance activity with rest to avoid flare-ups caused by overuse.”
Weight management is another key factor in controlling osteoarthritis symptoms. “Maintaining a healthy body weight is especially important,” says Dr Hughes. “Extra weight places additional load on joints, particularly the knees and hips, which can worsen pain and accelerate joint damage. Even modest weight loss has been shown to significantly reduce pain and improve mobility.”
Interestingly, diet can also play a role in managing inflammation linked to osteoarthritis. “Eating plenty of fresh fruit and vegetables, whole grains, nuts, and seeds, along with at least two portions of oily fish each week, provides antioxidants and omega-3 fatty acids that help reduce inflammation and protect against cell damage,” Dr Hughes explains.
“In my practice, I often recommend combining these dietary changes with natural supplements such as turmeric or GOPO to provide additional support for joint health.”
For patients hoping to reduce their dependence on NSAIDs, Dr Hughes stresses the importance of medical supervision.
“Any reduction in NSAIDs should be done gradually and under the guidance of a healthcare professional. This helps ensure pain remains well controlled while avoiding sudden flare-ups or withdrawal issues,” he says.
“By combining regular movement, physiotherapy, supportive nutrition, and appropriate natural supplements, many patients can take a more balanced approach to managing chronic joint pain. Over time, these strategies may allow people to rely less on medication while maintaining a good quality of life.”
Once rare, cancer diagnoses have become increasingly common as people continue to work long hours, suffer through high stress, have irregular meals, do not have a sleeping routine and have easy access to harmful substances such as alcohol and tobacco.
As officials sound the alarm over rising cases of colorectal and cervical cancer, Dr Sewanti Limaye, Head of Oncology at Sir H. N. Reliance Foundation Hospital & Research Centre, Mumbai, warns that oral cavity cancer cases are now as high as breast cancer cases.
“It’s been nine years now that I have been back in India, and the first few observations that I had were of the people working at my place with women chewing tobacco. I would run after them to spit it out.
"It’s such a common practice. Oral cavity cancers are also on the rise. Huge problem statement in India,” she told Soha Ali Khan while on her podcast.
Oral cancer is a wide term for cancer that affects the inside of your mouth and it typically presents itself as white patches or sores that bleed. It can occur on the:
Dr Hitesh Singhavi, consultant, head and neck oncosurgery, KIMS Hospitals, Thane noted: “Tobacco, chewing Areca nut, alcohol, chronic irritation from sharp teeth, and poor oral hygiene constantly irritate the mouth lining. Over the years, this ongoing damage hinders healing and raises the risk of abnormal cell growth. A small ulcer or patch can often go unnoticed."
Left untreated, oral cancer can easily spread throughout your mouth and throat to other areas of your head and neck, becoming metastatic and ultimately, incurable. Some common symptoms include:
Eating tobacco, drinking excessive alcohol, sun exposure on the lips, HPV exposure and a weakened immune system can increase the risk of developing oral cancer.
It is estimated that about 60,000 new cases of oral cancer are reported annually in India and five people die from the cause every hour. It is the most common cancer in Indian men and third most common in women, with roughly 20 in 100,000 people affected.
Unlike breast cancer, the rise in oral cancer cases is mostly due to an increase in tobacco use among women as this cancer is driven more by lifestyle exposure than by gender biology, according to Dr Singhavi.
“Unlike breast cancer, which is influenced by multiple biological and hormonal factors, oral cavity cancer is largely driven by lifestyle choices. This means that while the disease burden is high, it is also one of the most preventable cancers.
The rising numbers reflect not just medical risk, but a public health and behavioural challenge that needs far greater awareness and intervention,” the expert explained.
Doctors advise avoiding tobacco in any form, cutting down on alcohol, maintaining oral hygiene, staying active and seeking prompt evaluation for persistent mouth changes can greatly reduce risk.
“Oral cavity cancer is mostly preventable. Being aware of daily habits and paying attention to minor symptoms can stop the disease before it progresses,” said Dr Singhavi.
© 2024 Bennett, Coleman & Company Limited